CoChat

Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum

Open access
Hengartner, Michael P., Schulthess, Lukas, Sorensen, Anders, Framer, Adele · 2020 · Therapeutic Advances in Psychopharmacology

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index; 29 of the 107 sources its claims cite were checked for support.

Abstract

Background: Protracted withdrawal syndrome (PWS) after stopping antidepressants (frequently also referred to as post-acute withdrawal syndrome or PAWS) has been described in a few case reports. However, a detailed quantitative analysis of specific symptom manifestations in antidepressant PWS is still lacking. Methods: We extracted patient narratives from a large English-language internet forum SurvivingAntidepressants.org , a peer support site concerned about withdrawal from antidepressants. PWS was ascertained based on diagnostic criteria proposed by Chouinard and Chouinard, specifically ⩾6 months of continuous antidepressant use, with emergence of new and/or more intense symptoms after discontinuation that last beyond the initial 6 weeks of acute withdrawal. We assessed medication history, outcome of PWS, and the prevalence of specific symptoms. Results: In total, n = 69 individual reports of protracted withdrawal were selected for analysis. At time of the subjects’ most recent reports, duration of PWS ranged from 5 to 166 months, mean = 37 months, median = 26 months. Length of time on the antidepressant causing protracted withdrawal ranged from 6 to 278 months, mean = 96 months, and median = 79 months. Throughout the withdrawal experience, affective symptoms, mostly anxiety, depression, emerging suicidality and agitation, were reported by 81%. Somatic symptoms, mostly headache, fatigue, dizziness, brain zaps, visual changes, muscle aches, tremor, diarrhea, and nausea were reported by 75%. Sleep problems (44%) and cognitive impairments (32%) were mentioned less frequently. These broad symptom domains were largely uncorrelated. Conclusion: PWS or PAWS from antidepressants can be severe and long-lasting, and its manifestations clinically heterogeneous. Long-term antidepressant exposure may cause multiple body system impairments. Although both somatic and affective symptoms are frequent, they are mostly unrelated in terms of occurrence. Proper recognition and detection of PWS thus requires a comprehensive assessment of medication history, duration of the withdrawal syndrome, and its various somatic, affective, sleep, and cognitive symptoms.

Overview

CoChat Summary

TL;DR

In 69 consumer narratives meeting proposed criteria for protracted withdrawal syndrome (PWS) after stopping antidepressants, symptoms were severe, clinically heterogeneous, and often long-lasting, with PWS duration ranging from 5 to 166 months. Affective and somatic symptoms were the most common but largely uncorrelated, suggesting PWS requires broad assessment across symptom domains.

Key findings

  • Among 69 PWS cases, duration of PWS at last report ranged from 5 to 166 months (mean = 37, median = 26), and time on the implicated antidepressant ranged from 6 to 278 months (mean = 96, median = 79).
  • Affective symptoms were reported by 81% (abstract; 82.6% in results), most commonly anxiety (64.9%), depression (43.9%), and emerging suicidality (24.6%); somatic symptoms were reported by 75% (abstract; grouped somatic syndrome 73.9% in results), most commonly headache, fatigue, dizziness, brain zaps, visual changes, muscle aches, tremor, diarrhea, and nausea.
  • Sleep problems were reported by 44% and cognitive impairments by 32%; broad symptom domains were largely uncorrelated, with somatic and affective symptoms weakly associated (r = 0.16, p = 0.18).
  • Reinstatement of the suspected antidepressant resolved PWS in 9 of 19 who attempted it; 2 subjects died by suicide, and more than one-third were lost to follow-up.

Methods

  • The authors extracted 94 pseudonymous patient narratives tagged as potential PWS from SurvivingAntidepressants.org, then applied Chouinard and Chouinard criteria: continuous antidepressant use for at least 6 months and withdrawal symptoms persisting beyond 6 weeks, with new or more intense symptoms; 25 reports were excluded, leaving n = 69.
  • One author coded medication history, PWS outcome, and symptom presence/quality using Fava et al.’s symptom classification; coding was cross-validated by a second author, with discrepancies resolved by consensus.
  • Analyses were descriptive, with Pearson correlations/phi coefficients and 95% CIs computed via bias-corrected and accelerated bootstrapping based on 5000 samples; no correction for multiple testing was applied because analyses were exploratory.

Limitations

  • The paper states the sample was modest (n = 69), lacked power to analyze individual drugs or drug classes, and relied on spontaneous self-reports that were neither systematically assessed nor clinically validated; reported symptom rates are therefore likely conservative underestimates.
  • The authors note possible misattribution of symptoms to antidepressant withdrawal rather than mental disorder or undiagnosed medical condition, and their semantic analysis could not distinguish PWS-induced affective symptoms from emotional reactions to debilitation or true relapse.
  • The text also makes evident that age and gender could not be assessed consistently, eight cases involved discontinuation among other drugs with sometimes unclear timelines, and more than one-third of subjects were lost to follow-up, leaving PWS outcome unknown for many.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1177/2045125320980573

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Antidepressants suspected to precipitate PWS. PWS, protracted withdrawal syndrome.
Figure 1. Antidepressants suspected to precipitate PWS. PWS, protracted withdrawal syndrome.CC BY-NC · PubMed Central
Figure 2. Recorded duration of PWS among subjects at time of last report. Blue dots indicate the 9 who resolved with reinstatement of the antidepressant precipitating PWS. Blue diamonds indicate the 2 who benefited significantly from other subsequent psychotropic treatment; orange dots the 4 who experienced only some benefit. Green dots indicate the 4 who resolved naturally without subsequent drug treatment; yellow, the 12 who, at last report, were partially recovered; violet, 2 suicides. The gray dots indicate the remaining 36 individuals for whom resolution of PWS has not been reported. PWS, protracted withdrawal syndrome.
Figure 2. Recorded duration of PWS among subjects at time of last report. Blue dots indicate the 9 who resolved with reinstatement of the antidepressant precipitating PWS. Blue diamonds indicate the 2 who benefited significantly from other subsequent psychotropic treatment; orange dots the 4 who experienced only some benefit. Green dots indicate the 4 who resolved naturally without subsequent drug treatment; yellow, the 12 who, at last report, were partially recovered; violet, 2 suicides. The gray dots indicate the remaining 36 individuals for whom resolution of PWS has not been reported. PWS, protracted withdrawal syndrome.CC BY-NC · PubMed Central
Figure 3. Outcomes for subjects with PWS as recorded at time of last report. PWS, protracted withdrawal syndrome.
Figure 3. Outcomes for subjects with PWS as recorded at time of last report. PWS, protracted withdrawal syndrome.CC BY-NC · PubMed Central
Figure 4. Prevalence rates of protracted withdrawal symptoms. Somatic is a higher-order domain and comprises general, balance, sensory, visual, neuromotor, vasomotor, and gastrointestinal symptoms.
Figure 4. Prevalence rates of protracted withdrawal symptoms. Somatic is a higher-order domain and comprises general, balance, sensory, visual, neuromotor, vasomotor, and gastrointestinal symptoms.CC BY-NC · PubMed Central

Verification

Claims the paper makes

9 Valid · 3 Not valid · 31 Not checked · 82 Own results and interpretations

60 more claims · 1 with their cited sources checked

Create a free account to see all 125 claims and to verify the 78 references still open.

See all claims — free account
  • Probably not a substantial claim. 33
  • It may state two separate claims as one. 39

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 72 references

Research works printed but not linked: 3

  1. Kotzalidis GD, 2007, Clin Neuropsychiatry, 4, 61
  2. Schatzberg AF, 1997, J Clin Psychiatry, 58, 5
  3. Becker HC., 2008, Alcohol Res Health, 31, 348

Cited by

See all 83

Metadata

Authors
Hengartner, M. P., Schulthess, L., Sorensen, A., & Framer, A.
Affiliations
  • University of Zurich (CH)
  • ZHAW Zurich University of Applied Sciences (CH)
  • Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark
Corresponding author
Hengartner, Michael P.
Venue
Therapeutic Advances in Psychopharmacology
Published
2020-01
Volume
10
Pages
2045125320980573-2045125320980573
ISSN
  • 2045-1253 (ISSN-L)
  • 2045-1261
OpenAlex
W3115093202
Cited by
74
References
72
Citations by year
2026: 21 · 2025: 8 · 2024: 10 · 2023: 6 · 2022: 18 · 2021: 11
FWCI
5.24
Type
journal article
Language
en
Open access
Locations
  • Therapeutic Advances in Psychopharmacology (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Zürcher Hochschule für Angewandte Wissenschaften digital collection (Zurich University of Applied Sciences) (submittedVersion, cc-by-nc-nd)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • ZHAW Digital Collection (cc-by-nc)
Funders
Stefan Hearst (na)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
Keywords
antidepressant discontinuation, patient narratives, online forums, peer support, somatic symptoms, affective symptoms, anxiety, depression, suicidality, sleep disorders, cognitive impairment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum. https://app.cochat.ai/papers/10.1177/2045125320980573
The paper
Hengartner, M. P., Schulthess, L., Sorensen, A., & Framer, A. (2020). Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum. Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125320980573

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.